Tata Sons’ board approved over Rs 10,000 crore for Air India’s capital infusion. This significant funding is contingent upon business cases from Air India and other group companies. The airline reported substantial losses, necessitating this financial support for its transformation. Singapore Airlines also faces a decision regarding its participation in the equity raise. This capital infusion comes amid internal discussions on group strategy and financial discipline.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.